ADMA Biologics, Inc.
ADMA
Jodie situation report
ADMA Biologics, Inc.'s move is spreading beyond its market group.
ADMA accounts for 15.4% of the group's measured movement across 8.3 effective names. raw member direction is mixed; 8 of 12 session-normalized paths align to the downside. Capital-flow agreement is 30%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
ADMA was the first measured mover. ADMA crossed its material path threshold at 10:00 ET. PTGX, IONS, SRRK followed.
- Revenue increased 2.0% versus the comparable filing period.
8 of 13 members in Biotechnology Therapeutics are active. 0 of 8 disclosed connections are confirming.
- At least 9 of 13 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- NBIX remains aligned with the group in the next market snapshot.
Invalidation: The live read weakens if participation falls to 4 of 13 members or fewer.
Who this business touches
The relationships behind ADMA
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
JPMJP Morgan Chase & Co.lenderMay 6, 2026 ▾
“JPM Credit Agreement On August 5, 2025 (the “JPM Closing Date”), we entered into a Credit Agreement (the “JPM Credit Agreement”) with the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent.”
GRFSFiling-linked namecompetitorFeb 25, 2026 ▾
“In December 2018, our former contract manufacturer assigned its rights and obligations under the 2011 Plasma Purchase Agreement to Grifols Worldwide Operations Limited (“Grifols”) as its successor-in-interest, effective January 2019.”
Depended on by
HTGCHercules Capital, Inc.investeeOct 30, 2025 ▾
“Our gains were offset by gross realized losses of $3.3 million and $15.0 million, respectively, for the three and nine month periods, from the write-off of equity and warrant investments in Proterra, Inc., The Faction Group LLC, Udacity, Inc., Humanigen, Inc.…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 5 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ADMA is currently a Participant in the organic co-movement group Biotechnology Therapeutics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.